BE904586A - Urogastrone. - Google Patents

Urogastrone.

Info

Publication number
BE904586A
BE904586A BE0/216524A BE216524A BE904586A BE 904586 A BE904586 A BE 904586A BE 0/216524 A BE0/216524 A BE 0/216524A BE 216524 A BE216524 A BE 216524A BE 904586 A BE904586 A BE 904586A
Authority
BE
Belgium
Prior art keywords
urogastrone
site
medicament
human urogastrone
homeothermic
Prior art date
Application number
BE0/216524A
Other languages
English (en)
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of BE904586A publication Critical patent/BE904586A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Utilisation de l'urogastrone humaine ou d'un fragment d'urogastrone humaine pour la préparation d'un médicament propre à favoriser la régénération osseuse et/ou tendineuse. Le médicament se prete à l'administration topique ou parentérale et est administré par préférence directement au site de la lésion ou à un site qui en est fort proche. Ce médicament convient de façon générale pour tous les organismes homéothermes.
BE0/216524A 1985-04-12 1986-04-11 Urogastrone. BE904586A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858509448A GB8509448D0 (en) 1985-04-12 1985-04-12 Urogastrone

Publications (1)

Publication Number Publication Date
BE904586A true BE904586A (fr) 1986-10-13

Family

ID=10577560

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/216524A BE904586A (fr) 1985-04-12 1986-04-11 Urogastrone.

Country Status (7)

Country Link
US (1) US4731357A (fr)
JP (1) JPS61293925A (fr)
BE (1) BE904586A (fr)
DE (1) DE3612232A1 (fr)
FR (1) FR2580175B1 (fr)
GB (2) GB8509448D0 (fr)
IT (1) IT1188650B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5070188A (en) * 1989-07-24 1991-12-03 Ethicon, Inc. Acylated epidermal growth factor
US5219998A (en) * 1990-06-04 1993-06-15 Levin Robert H Yeast-derived epidermal growth factor
US5434135A (en) * 1990-08-02 1995-07-18 Indu Parikh Growth factor compositions, preparation and use
DK0541726T3 (da) * 1990-08-02 2000-08-21 Indu Parikh Vækstfaktorsammensætninger, fremstilling og anvendelse
US5741895A (en) * 1990-08-21 1998-04-21 The Regents Of The University Of California Identification of cell density signal molecule
US20060014684A1 (en) * 2000-03-03 2006-01-19 University Technologies International Inc. Novel uses of EGF

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1394846A (en) * 1972-11-29 1975-05-21 Ici Ltd Polypeptides
EP0105014B1 (fr) * 1982-09-24 1992-05-20 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Rétablissement de tissu chez les animaux

Also Published As

Publication number Publication date
GB8509448D0 (en) 1985-05-15
IT8620063A1 (it) 1987-10-11
GB2173700A (en) 1986-10-22
FR2580175A1 (fr) 1986-10-17
US4731357A (en) 1988-03-15
FR2580175B1 (fr) 1990-03-02
IT8620063A0 (it) 1986-04-11
GB2173700B (en) 1989-06-21
GB8608730D0 (en) 1986-05-14
DE3612232A1 (de) 1986-10-16
IT1188650B (it) 1988-01-20
JPS61293925A (ja) 1986-12-24

Similar Documents

Publication Publication Date Title
FI103180B (fi) Flurbiprofeenia sisältävien lääkkeiden valmistus kipujen ja/tai tulehd usten torjumiseksi eläimissä ja ihmisissä
IT1199760B (it) Dispositivo terapeutico per la somministrazione di medicamenti
DE3682457D1 (de) Geraet zur verabreichung von medikamenten an patienten.
DE3680943D1 (de) Therapeutische mittel zur oralen verabreichung.
IT8647603A0 (it) Procedimento di trattamento per forme farmaceutiche di dosaggio rivestite per ridurne la collosita'
DE3582439D1 (de) Mittel zur behandlung von herzerkrankungen.
DE68910159D1 (de) Dosierform für Verabreichung in der Humanmedizin.
EP0177342A3 (fr) Formulations orales de protéines thérapeutiques
DE3682229D1 (de) Zur stimulierung der traenensekretion verwendbare pharmazeutische praeparate.
BE904586A (fr) Urogastrone.
DE69004532D1 (de) Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen.
ATE94763T1 (de) Medikament zur behandlung von fibrotischer stoerung und antifibrotische verbindung.
ATE89737T1 (de) Behandlung von leukozytstoerungen mit gm-csf.
BG44709A3 (bg) Метод за получаване на 9-хлор-1,5-бензотиазепинови производни
IT8647612A0 (it) Preparato per la cura e l'igiene della bocca
IT8423896A0 (it) Diacilderivati della glicerilfosforilcolina ad attivita' terapeutica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
KR900009029A (ko) 가축병 치료용 약물을 투여하는 장치
EP0279867A3 (fr) Emploi de vitamine E et association de vitamine E avec des antiphlogistiques et analgésique pour le traitement de maladies rhumatismales
EG17992A (en) Preparation of a medicament for arthritis and theumatism
SU1553129A1 (ru) Способ лечени альгоменореи
IT1214915B (it) Derivato dell'acido 4-metossiisoftalico con attivita'farmacologica in disordini tromboembolici e procedimento per la sua preparazione
SE8704081D0 (sv) A new prohylactic method
FR2568124B1 (fr) Medicament pour traiter les etats hypotrophiques par administrations d'aspartate d'arginine
IT8520712A0 (it) Formulazioni farmaceutiche per stimolare la liberazione di ormone somatotropo.
IT207409Z2 (it) Mutandina-assorbente monouso perl'igiene intima femminile e simili applicazioni

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: IMPERIAL CHEMICAL INDUSTRIES PLC

Effective date: 19940430